HealthLinx
Vermillion said this week that at its annual meeting on March 21, shareholders elected Robert Goggin to the company's board of directors.
John Evans has resigned as a non-executive director of Healthlinx due to increasing work commitments elsewhere. In his place, the company has appointed Malcolm Lucas-Smith.
Australian diagnostics firm Healthlinx said last week that its deal to sell intellectual property related to its OvPlex ovarian cancer diagnostic to San Diego-based start-up Mane Cancer Diagnostics has expired.
Mane Cancer Diagnostics has requested an extension of deadlines related to its acquisition of Healthlinx's OvPlex ovarian cancer test.
The request was noted in an address to investors last month by Healthlinx chairman Gregory Rice.
This article has been updated from a version posted Oct. 12 to include additional information.
Oct 5, 2012
Jul 6, 2012
Jul 6, 2012
Jun 29, 2012
Apr 6, 2012
Dec 16, 2011
Nov 18, 2011
Feb 25, 2011
Jan 7, 2011
Dec 17, 2010
Dec 2, 2010